annb0t
Top 20
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, delivered an adjusted loss per share of 20 cents in fourth-quarter 2024, narrower than the year-ago adjusted loss of 27 cents per share. The adjusted loss per share was in line with the Zacks Consensus Estimate.
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
The companyâs GAAP earnings per share (EPS) was a penny in the quarter against the year-ago periodâs loss of 31 cents.
Full-year a...
>>> Read more: PACB Stock Down Following In-Line Q4 Earnings, Revio Shipments Fall
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
The companyâs GAAP earnings per share (EPS) was a penny in the quarter against the year-ago periodâs loss of 31 cents.
Full-year a...
>>> Read more: PACB Stock Down Following In-Line Q4 Earnings, Revio Shipments Fall
